TITLE

Inflammatory cells in the airways in COPD

AUTHOR(S)
O'Donnell, R.; Breen, D.; Wilson, S.; Djukanovic, R.
PUB. DATE
May 2006
SOURCE
Thorax;May2006, Vol. 61 Issue 5, p448
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Airway inflammation is central to the pathogenesis of both airway remodelling and parenchymal destruction in chronic obstructive pulmonary disease (COPD). Neutrophils, macrophages, and CD8+ T lymphocytes have been implicated in a number of studies, but a detailed profile of disease-phenotype specific inflammation has yet to emerge. The heterogeneity of the disease has hindered data interpretation while extrapolation of the results of relatively non-invasive studies to the actual pathology found in the distal lung is difficult. Moreover, prominent studies have had frequently conflicting results. Further investigations are needed to marry the different clinical phenotypes of COPD to their respective inflammatory profiles in the airways and thus improve our understanding of the pathogenesis of the disease as a whole.
ACCESSION #
21039847

 

Related Articles

  • Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Singh, Dave; Edwards, Lisa; Tal-Singer, Ruth; Rennard, Stephen // Respiratory Research;2010, Vol. 11, p77 

    Introduction: The percentage of neutrophils in sputum are increased in COPD patients, and may therefore be a biomarker of airway inflammation. We studied the relationships between sputum neutrophils and FEV1, health status, exacerbation rates, systemic inflammation and emphysema, and long term...

  • Asthma: alternative anti-inflammatory agents needed for patient subgroup.  // PharmaWatch: Monthly Review;Mar2005, Vol. 4 Issue 3, p26 

    The article presents a study conducted by the European Network for Understanding Mechanisms of Severe Asthma, concerning the role of the neutrophil in the pathogenesis of asthma. It has suggested that severe asthma is a different disease to mild-moderate disease. The presence of neutrophilic...

  • Cytokines as Targets in Chronic Obstructive Pulmonary Disease. Chung, K. F. // Current Drug Targets;Jun2006, Vol. 7 Issue 6, p675 

    Chronic obstructive pulmonary disease [COPD] is characterised by airflow limitation of peripheral airways that is not fully reversible and progressive and is associated with an abnormal inflammatory response of the lungs to noxious particles or gases. There is also intense airway wall...

  • Association of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokers. Willemse, Brigitte W. M.; Hacken, Nick H. T. Ten; Rutgers, Bea; Postma, Dirkje S.; Timens, Wim // Respiratory Research;2005, Vol. 6, p38 

    Background: Inflammation in the airways and lung parenchyma underlies fixed airway obstruction in chronic obstructive pulmonary disease. The exact role of smoking as promoting factor of inflammation in chronic obstructive pulmonary disease is not clear, partly because studies often do not...

  • The Molecular Mechanisms of Glucocorticoids-Mediated Neutrophil Survival. Saffar, Arash S.; Ashdown, Heather; Gounni, Abdelilah S. // Current Drug Targets;Apr2011, Vol. 12 Issue 4, p556 

    No abstract available.

  • Airway Clearance of Apoptotic Cells in COPD. Mukaro, Violet R. S.; Hodge, Sandra // Current Drug Targets;Apr2011, Vol. 12 Issue 4, p460 

    No abstract available.

  • Airway inflammation contributes to health status in COPD: a cross-sectional study. Snoeck-Stroband, Jiska B.; Postma, Dirkje S.; Lapperre, Thérèse S.; Gosman, Margot M. E.; Thiadens, Henk A.; Kauffman, Henk F.; Sont, Jacob K.; Jansen, Désirée F.; Sterk, Peter J. // Respiratory Research;2006, Vol. 7, p140 

    Background: Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airflow limitation and airway inflammation, accompanied by decreased health status. It is still unknown which factors are responsible for the impaired health status in COPD. We postulated that airway...

  • The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPD. Russell, Kirsty E.; Chung, Kian Fan; Clarke, Colin J.; Durham, Andrew L.; Mallia, Patrick; Footitt, Joseph; Johnston, Sebastian L.; Barnes, Peter J.; Hall, Simon R.; Simpson, Karen D.; Starkey, Malcolm R.; Hansbro, Philip M.; Adcock, Ian M.; Wiegman, Coen H. // PLoS ONE;1/11/2016, Vol. 11 Issue 1, p1 

    Introduction: Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine associated with acute and chronic inflammatory disorders and corticosteroid insensitivity. Its expression in the airways of patients with chronic obstructive pulmonary disease (COPD), a relatively steroid...

  • Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Caramori, G.; Romagnoli, M.; Casolari, P.; Bellettato, C.; Casoni, G.; Boschetto, P.; K. Fan Chung; Barnes, P.J.; Adcock, I.M.; Ciaccia, A.; Fabbri, L.M.; Papi, A. // Thorax;Apr2003, Vol. 58 Issue 4, p348 

    Background: Exacerbations represent an important feature of the clinical manifestation and natural history of chronic obstructive pulmonary disease (COPD). Nuclear Iocalisation of p65 is a signal of nuclear factor-κB (NF-κB) activation. A study was undertaken to evaluate whether NF-κB...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics